Finlay Institute

Finlay Institute
AddressAvenida 21 No. 19810
Location
Havana
,
Cuba
Coordinates23°04′23″N 82°27′27″W / 23.0731°N 82.4576°W / 23.0731; -82.4576Coordinates: 23°04′23″N 82°27′27″W / 23.0731°N 82.4576°W / 23.0731; -82.4576
Websitewww.finlay.edu.cu

The Finlay Institute (Instituto Finlay de Vacunas lit. Finlay Vaccine Institute) is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[1]

In response to fight against Covid-19, Finlay Institute has developed the Soberana 02.[2] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[3]

References

  1. ↑ Chaves-Carballo, Enrique (October 2005). "Carlos Finlay and Yellow Fever: Triumph over Adversity". Military Medicine. 170 (10): 881–885. doi:10.7205/MILMED.170.10.881. PMID 16435764.
  2. ↑ Reardon, Sara (22 November 2021). "Cuba's bet on home-grown COVID vaccines is paying off". Nature. pp. 15–16. doi:10.1038/d41586-021-03470-x.
  3. ↑ Cuba pospone el inicio de la vacunación con Soberana 14ymedio, 8 mars 2021
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.